You are here

  • Home
  • Archive
  • Volume 21, Issue 7
  • Feasibility and Surgical Outcomes of Laparoscopic Metastasectomy in the Treatment of Ovarian Metastases From Gastric Cancer

Article Text

Article menu
Download PDFPDF
Surgeons Corner
Feasibility and Surgical Outcomes of Laparoscopic Metastasectomy in the Treatment of Ovarian Metastases From Gastric Cancer
  1. Maria Lee, MD,
  2. Jiheum Paek, MD,
  3. San Hui Lee, MD,
  4. Ga Won Yim, MD,
  5. Sang Wun Kim, MD, PhD,
  6. Sunghoon Kim, MD, PhD,
  7. Jae Hoon Kim, MD, PhD,
  8. Young Tae Kim, MD, PhD and
  9. Eun Ji Nam, MD
  1. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Republic of Korea.
  1. Address correspondence and reprint requests to Eun Ji Nam, MD, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Yonsei, University College of Medicine, 250 Seongsanno, 134 Shinchon-dong, Seodaemun-gu, 120-752 Seoul, Republic of Korea. E-mail: nahmej6{at}yuhs.ac.

Abstract

Objectives: This study aimed to evaluate the feasibility of laparoscopic metastasectomy (LM) in the treatment of ovarian metastases from gastric cancer and to compare the surgical outcomes with patients who underwent open metastasectomy (OM).

Methods: The cases of 73 patients who underwent LM (n = 16) or OM (n = 57) were retrospectively reviewed. All patients were diagnosed with gastric cancer and, subsequently, underwent a metastasectomy at Yonsei University Health System between December 2002 and March 2011.

Results: Sixteen operations were completed laparoscopically with no conversion to laparotomy. Complete cytoreduction surgery was achievable in 13 patients (81.3%). Operating time, complete cytoreduction, and occurrence of perioperative complications were comparable between the 2 groups. The LM group had less blood loss (25 vs 400 mL, P < 0.0001), earlier return to a general diet (3 vs 4 days, P = 0.005), shorter postoperative hospital stay (4.5 vs 7 days, P < 0.0001), and lower postoperative pain scores after 6, 24, and 48 hours than those in the OM group. There were no operative complications in the LM group.

Conclusions: As a surgical treatment for ovarian metastases from gastric cancer, LM is feasible and provides benefits to patients without detrimental effects on the clinical outcomes for selected patients.

  • Laparoscopy
  • Metastasectomy
  • Ovarian metastases
  • Gastric cancer

https://doi.org/10.1097/IGC.0b013e31822620e3

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • This study was supported by grants from the Yonsei University Research Fund of 2010 (6-2010-0006), a Faculty Research Grant of Yonsei University College of Medicine 2009 (6-2009-0127), and the National Research Foundation of Korea Grant, funded by the Korean Government (7-2011-0245).

    • The authors have no conflicts of interest or financial ties to disclose.